Table 1 Demographic characteristics of study population.

From: Night-shift work, circadian and melatonin pathway related genes and their interaction on breast cancer risk: evidence from a case-control study in Korean women

Characteristics

Controls (N = 941)

Cases (N = 959)

p-valuea

N

%

N

%

Age group (years)

    

0.538

   ≤29

21

2.24

22

2.29

 

   30–39

102

10.84

124

12.93

 

   40–49

424

45.06

444

46.30

 

   50–59

293

31.14

288

30.03

 

   60–69

91

9.67

75

7.82

 

   ≥70

10

1.06

6

0.63

 

Number of pregnancies

    

<0.001

   Nullipara

96

10.20

125

13.03

 

   1–2

279

29.65

327

34.10

 

   ≥3

482

51.22

503

52.45

 

Age at birth of first child (years)

    

<0.001

   Nullipara

96

10.20

125

13.03

 

   <28

481

51.12

461

48.07

 

   ≥28

252

26.78

341

35.56

 

Education

    

0.902

   <High school

359

38.15

372

38.79

 

   ≥University

416

44.21

425

44.32

 

BMI (kg/m2)

    

<0.001

   <18.5

671

71.31

677

70.59

 

   ≥18.5–24.9

53

5.63

39

4.07

 

   ≥25

151

16.05

226

23.57

 

Age at menarche (years)

    

<0.001

   ≤14

558

59.30

681

71.02

 

   >14

311

33.05

276

28.78

 

Tobacco smoking

    

<0.001

   Never

804

85.44

846

88.22

 

   Ever

78

8.29

113

11.78

 

Alcohol drinking

    

<0.001

   Never

476

50.58

681

71.01

 

   Ever

406

43.15

278

28.99

 

Use of female hormone treatment in menopausal womenb

    

0.197

   Never

239

25.40

278

28.99

 

   Ever

81

8.61

74

7.72

 

Family history of breast cancer in first degree relatives

    

<0.001

   No

745

79.17

706

73.62

 

   Yes

129

13.71

231

24.09

 

Menopausal status

    

<0.001

   Premenopause

416

44.21

575

59.96

 

   Postmenopause

525

55.79

384

40.04

 

Night shift work experience

    

0.497

   Never

862

91.60

870

90.72

 

   Ever

79

8.40

89

9.28

 

Duration of night shift work

    

0.459

   Never

862

90.72

870

90.72

 

   <2 years

33

3.51

32

3.34

 

   ≥2 years

43

4.57

56

5.84

 

   Unknown

3

0.32

1

0.10

 

Estrogen receptor

   Negative

 

338

35.25

 

   Positive

 

586

61.11

 

   Unknown

 

35

3.65

 

Progesteron receptor

   Negative

 

400

41.71

 

   Positive

 

525

54.74

 

   Unknown

 

34

3.55

 

Human epidermal growth factor receptor 2

   Negative

 

697

72.68

 

   Positive

 

173

18.04

 

   Unknown

 

89

9.28

 
  1. N: number; BMI: body mass index (kg/m2); ap value of chi-square test; bin postmenopausal women.